# 04_QA_REPORT.md

# Quality Assurance Report

---

# Identity

| Field | Value |
|---|---|
| QA Report ID | QA-PP-0154 |
| Population Package | PP-0154 |
| Title | Hereditary Gastric Cancer Risk Assessment |
| Version | 1.0.0 |
| Status | PASS |

---

# 1. Content QA

| Criterion | Result |
|---|---|
| Assessment-layer clinical question | PASS |
| Personal history included | PASS |
| Three-generation family history included | PASS |
| Maternal/paternal lineage included | PASS |
| Pedigree included | PASS |
| Age at diagnosis included | PASS |
| Histology included | PASS |
| Gastric polyps/precursor findings included | PASS |
| Pathology verification included | PASS |
| Hereditary red flags included | PASS |
| Differential hereditary pathways included | PASS |
| Incomplete family-history limitations included | PASS |
| Variant probability vs cancer risk distinguished | PASS |
| Risk-model limitations included | PASS |
| Transition to genetic testing included | PASS |
| Tumor-testing clue boundary included | PASS |

---

# 2. Clinical QA

| Criterion | Result |
|---|---|
| NCI Gastric Cancer Genetics PDQ prioritized | PASS |
| NCI Cancer Genetics Risk Assessment PDQ used | PASS |
| Three-generation assessment preserved | PASS |
| Maternal and paternal lineage preserved | PASS |
| Histology importance preserved | PASS |
| Verification principle preserved | PASS |
| Hereditary red flags preserved | PASS |
| Family-history limitations preserved | PASS |
| No unsupported gastric-specific risk calculator | PASS |
| No unsupported numerical risk thresholds | PASS |
| Somatic finding not equated with germline diagnosis | PASS |
| Risk assessment not equated with diagnosis | PASS |
| Risk assessment not equated with automatic testing | PASS |

---

# 3. Educational QA

| Criterion | Result |
|---|---|
| Plain-language framing | PASS |
| Assessment versus testing clearly distinguished | PASS |
| Family history versus genetic diagnosis distinguished | PASS |
| Genetic risk versus cancer risk distinguished | PASS |
| Histology importance clearly stated | PASS |
| Common misconceptions addressed | PASS |
| No deterministic language | PASS |
| No individualized risk calculation | PASS |
| No individualized testing recommendation | PASS |

---

# 4. Governance QA

| Criterion | Result |
|---|---|
| CKO completed | PASS |
| Knowledge Passport completed | PASS |
| Evidence Package completed | PASS |
| QA Report completed | PASS |
| Gold Specification v1.0 followed | PASS |
| Approved Decision Batch implemented | PASS |
| Renamed title applied | PASS |
| Scope not reopened after approval | PASS |
| Evidence traceability documented | PASS |
| Knowledge Graph documented | PASS |
| Boundary/overlap declared | PASS |
| Versioning complete | PASS |

---

# 5. Boundary / Overlap QA

## PP-0015 — Hereditary Gastric Cancer

PP-0015 owns the broad hereditary gastric-cancer landscape.

PP-0154 owns the **assessment process**.

**Result: PASS**

## PP-0016 — Genetic Testing

PP-0016 owns general genetic-testing concepts/process.

PP-0154 owns the **clinical rationale leading toward testing**.

**Result: PASS**

## PP-0152 — HDGC Genetic Testing Criteria

PP-0152 owns exact HDGC eligibility criteria.

PP-0154 routes to those criteria and does not duplicate them.

**Result: PASS**

## PP-0149 — HDGC

PP-0149 owns established HDGC syndrome and management.

PP-0154 only recognizes an HDGC-suggestive pattern and delegates downstream.

**Result: PASS**

## PP-0150 — CDH1

PP-0150 owns CDH1-specific germline pathogenic variants and interpretation.

PP-0154 only recognizes CDH1 as one hereditary pathway.

**Result: PASS**

## PP-0151 — CTNNA1

PP-0151 owns CTNNA1-specific germline variants and interpretation.

PP-0154 only recognizes CTNNA1 as one hereditary pathway.

**Result: PASS**

## PP-0153 — HDGC-like Families

PP-0153 owns the genetically unresolved HDGC-like state and its management implications.

PP-0154 only identifies when such a downstream pathway may become relevant.

**Result: PASS**

## PP-0110 / PP-0113 / PP-0114

These packages own somatic testing, molecular profiling and genomic biomarker knowledge.

PP-0154 only uses prior tumor testing as a potential clue in hereditary-risk assessment.

**Result: PASS**

---

# 6. Clinical Safety QA

| Safety Item | Result |
|---|---|
| No individual hereditary-risk calculation | PASS |
| No automatic genetic-testing recommendation | PASS |
| No individual diagnosis | PASS |
| No germline inference from tumor-only finding | PASS |
| No unsupported risk percentages | PASS |
| No universal risk calculator created | PASS |
| No syndrome-specific management added | PASS |
| No gene-specific penetrance added | PASS |
| Family-history uncertainty preserved | PASS |
| Clinical judgment preserved | PASS |

---

# 7. Evidence Traceability QA

Primary:

- NCI Genetics of Gastric Cancer (PDQ®)
- NCI Cancer Genetics Risk Assessment and Counseling (PDQ®)

Supporting:

- NCI Hereditary Diffuse Gastric Cancer (PDQ®)
- relevant project guideline materials

The package uses these sources to support the assessment framework, while exact syndrome-specific decisions remain delegated.

---

# 8. Scope Integrity QA

### Correctly Included

- personal history;
- three-generation family history;
- maternal/paternal lineage;
- pedigree;
- age;
- histology;
- pathology verification;
- hereditary red flags;
- hereditary differential;
- incomplete family-history limitations;
- variant probability versus cancer risk;
- risk-model concepts;
- testing transition;
- tumor-testing clue boundary.

### Correctly Excluded

- exact HDGC criteria;
- CDH1/CTNNA1 interpretation;
- HDGC/HDGC-like management;
- detailed genetic testing;
- detailed counseling;
- individualized risk calculations;
- variant classification;
- somatic interpretation.

**Result: PASS**

---

# 9. Knowledge Graph QA

### Assessment Layer

**PP-0154 — Hereditary Gastric Cancer Risk Assessment**

↓

### Disease-specific eligibility

**PP-0152 — HDGC Genetic Testing Criteria**

↓

### Gene-level interpretation

**PP-0150 — CDH1**

**PP-0151 — CTNNA1**

↓

### Syndrome/post-testing state

**PP-0149 — HDGC**

**PP-0153 — HDGC-like Families**

Parallel:

**PP-0015 — Hereditary Gastric Cancer**

**PP-0016 — Genetic Testing**

**PP-0110 / PP-0113 / PP-0114 — Molecular branch**

**Result: PASS**

---

# 10. Gold Artifact QA

| Artifact | Present | Status |
|---|---|---|
| 01_CKO.md | Yes | PASS |
| 02_KNOWLEDGE_PASSPORT.md | Yes | PASS |
| 03_PRIMARY_EVIDENCE_PACKAGE.md | Yes | PASS |
| 04_QA_REPORT.md | Yes | PASS |

---

# 11. Final QA Decision

# PASS

PP-0154 satisfies the locked Gold Population Package requirements.

The package establishes a clean assessment layer:

**PP-0154 = ASSESS HEREDITARY RISK**

↓

**PP-0152 = APPLY HDGC TESTING CRITERIA**

↓

**PP-0150 / PP-0151 = INTERPRET GENE RESULTS**

↓

**PP-0149 / PP-0153 = MANAGE ESTABLISHED OR UNRESOLVED HDGC STATE**

No unsupported risk calculator, numerical threshold, germline inference, or syndrome-specific management has been introduced.

---

# Final Status

**APPROVED — GOLD / QA PASS**
